What question did this study set out to answer?

To compare perioperative complications and safety outcomes between axillary and femoral artery cannulation in patients undergoing robotic-assisted minimally invasive coronary artery bypass surgery.

September 17, 2026Acibadem Universitesi Saglik Bilimleri DergisiOpen Access

Safety and Feasibility of Axillary Artery Cannulation In Robotic Assisted Minimally Invasive Coronary Revascularization

View Full Paper

Ask AI

Bookmark

Authors

GAGökhan Arslanhan ZÖZeynep Sıla Özcan MBMurat Baştopçu

Discussion

Member takes

Overview

Retrospective cohort study demonstrates zero mortality or stroke with axillary cannulation in robotic coronary bypass surgery, indicating a safe alternative for patients with vascular disease.

Key Points

To compare perioperative complications and safety outcomes between axillary and femoral artery cannulation in patients undergoing robotic-assisted minimally invasive coronary artery bypass surgery.
Retrospective review of 96 consecutive patients undergoing on-pump robotic-assisted minimally invasive coronary artery bypass surgery between March 2022 and May 2024 at a single institution.
Preoperative computed tomography scans guided arterial cannulation strategy, assigning 57 patients (59.4%) to axillary cannulation and 39 patients (40.6%) to femoral cannulation.
Primary endpoints evaluated included in-hospital mortality, stroke, and cannulation-related complications such as neurovascular injury and infection.
Zero cases of in-hospital mortality (0/57 vs 0/39) or stroke (0/57 vs 0/39) occurred in either the axillary or femoral cannulation groups.
Neither group experienced hematomas, cannulation site infections, arterial dissections, systemic emboli, or brachial plexus injuries.
Cannulation-site seromas developed in 3 of 39 patients (7.7%) in the femoral cannulation group, compared to 0 of 57 patients (0.0%) in the axillary cannulation group.

Cite This Study

Arslanhan et al. (2026) studied this question.

synapsesocial.com/papers/6aabb68c5f706d05830e50e5 https://doi.org/10.31067/acusaglik.2033231

View Full Paper

Ask AI

Bookmark

September 17, 2026Acibadem Universitesi Saglik Bilimleri DergisiOpen Access

Safety and Feasibility of Axillary Artery Cannulation In Robotic Assisted Minimally Invasive Coronary Revascularization

View Full Paper

Ask AI

Bookmark

Authors

GAGökhan Arslanhan ZÖZeynep Sıla Özcan MBMurat Baştopçu

Discussion

Member takes

Overview

Retrospective cohort study demonstrates zero mortality or stroke with axillary cannulation in robotic coronary bypass surgery, indicating a safe alternative for patients with vascular disease.

Key Points

To compare perioperative complications and safety outcomes between axillary and femoral artery cannulation in patients undergoing robotic-assisted minimally invasive coronary artery bypass surgery.
Retrospective review of 96 consecutive patients undergoing on-pump robotic-assisted minimally invasive coronary artery bypass surgery between March 2022 and May 2024 at a single institution.
Preoperative computed tomography scans guided arterial cannulation strategy, assigning 57 patients (59.4%) to axillary cannulation and 39 patients (40.6%) to femoral cannulation.
Primary endpoints evaluated included in-hospital mortality, stroke, and cannulation-related complications such as neurovascular injury and infection.
Zero cases of in-hospital mortality (0/57 vs 0/39) or stroke (0/57 vs 0/39) occurred in either the axillary or femoral cannulation groups.
Neither group experienced hematomas, cannulation site infections, arterial dissections, systemic emboli, or brachial plexus injuries.
Cannulation-site seromas developed in 3 of 39 patients (7.7%) in the femoral cannulation group, compared to 0 of 57 patients (0.0%) in the axillary cannulation group.

Cite This Study

Arslanhan et al. (2026) studied this question.

synapsesocial.com/papers/6aabb68c5f706d05830e50e5 https://doi.org/10.31067/acusaglik.2033231

View Full Paper

Ask AI

Bookmark